Ainos, Inc. (AIMD) expands at-the-market common stock program with $1.35M capacity
Rhea-AI Filing Summary
Ainos, Inc. updated its at-the-market equity program with H.C. Wainwright to permit additional primary issuances of common stock with an aggregate offering price of up to $1,346,165 from time to time under the existing Sales Agreement.
Previously, Ainos sold $2,714,728.20 of securities under this agreement, including $1,960,544 pursuant to General Instruction I.B.6 of Form S-3 during the prior 12-month period. As of July 24, 2026, public float was approximately $9,920,125, based on 8,544,073 shares outstanding and a Nasdaq Capital Market price of $3.16 per share. The company states it will not sell more than one-third of its public float in any 12-month period while its public float remains below $75.0 million, in line with Form S-3 limitations.
Positive
- None.
Negative
- None.
Filing Explained
The supplement adds up to $1,346,165 of potential ATM issuance; no new sale is reported, so dilution and proceeds remain conditional.
On July 24, Ainos increased the amount of common stock it may offer through its existing at-the-market program to up to
An at-the-market program permits gradual sales at prevailing market prices, and any shares actually issued would increase the share count and reduce existing holders’ percentage ownership absent offsetting changes.
For context, Ainos reported
Sources and calculations
- Ainos prospectus supplement (2026-07-24)
- At-the-market program definition (2026-07-17)
- Dilution definition (2026-07-17)
- Ainos 2026 first-quarter fundamentals (2026Q1)
- Cash and equivalents vs quarterly operating cash outflow, in days of cash use $2,841,422 / ($983,421 / 90) = [object Object]
Key Figures
Key Terms
at the market offerings financial
General Instruction I.B.6 of Form S-3 regulatory
public float financial
At the Market Offering Agreement financial
Nasdaq Capital Market market
Offering Details
AI-generated analysis. How Rhea-AI works. Not financial advice.
